Gan & Lee Pharmaceuticals Co Ltd (603087) — Net Asset Momentum
Gan & Lee Pharmaceuticals Co Ltd (603087) recorded a net asset momentum of 5.2% as of December 2025, with net assets of CN¥11.63 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Gan & Lee Pharmaceuticals Co Ltd (603087) defensive interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Gan & Lee Pharmaceuticals Co Ltd Net Asset Momentum (2013–2025)
This chart tracks Gan & Lee Pharmaceuticals Co Ltd's year-over-year net asset growth across 13 annual reporting periods from 2013 to 2025. The most recent momentum reading is +5.2%, with net assets of CN¥11.63 Billion CNY as of December 2025. Read total liabilities of Gan & Lee Pharmaceuticals Co Ltd for a breakdown of total debt and financial obligations.
Annual Net Asset History for Gan & Lee Pharmaceuticals Co Ltd (2013–2025)
The table below shows the complete annual net asset history for Gan & Lee Pharmaceuticals Co Ltd from 2013 to 2025, covering 13 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 603087 market cap.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥11.63 Billion | CN¥12.63 Billion | CN¥998.57 Million | ▲ +5.2% |
| 2024 | CN¥11.05 Billion | CN¥12.04 Billion | CN¥988.45 Million | ▲ +2.9% |
| 2023 | CN¥10.74 Billion | CN¥11.72 Billion | CN¥972.52 Million | ▲ +12.1% |
| 2022 | CN¥9.59 Billion | CN¥10.61 Billion | CN¥1.02 Billion | ▼ -5.7% |
| 2021 | CN¥10.17 Billion | CN¥10.85 Billion | CN¥686.02 Million | ▲ +13.7% |
| 2020 | CN¥8.94 Billion | CN¥9.51 Billion | CN¥569.09 Million | ▲ +63.4% |
| 2019 | CN¥5.47 Billion | CN¥6.03 Billion | CN¥555.88 Million | ▲ +28.1% |
| 2018 | CN¥4.27 Billion | CN¥4.69 Billion | CN¥424.18 Million | ▲ +28.0% |
| 2017 | CN¥3.34 Billion | CN¥3.74 Billion | CN¥408.00 Million | ▲ +47.9% |
| 2016 | CN¥2.26 Billion | CN¥2.60 Billion | CN¥348.06 Million | ▲ +51.8% |
| 2015 | CN¥1.49 Billion | CN¥1.81 Billion | CN¥325.41 Million | ▲ +43.1% |
| 2014 | CN¥1.04 Billion | CN¥1.20 Billion | CN¥164.18 Million | ▲ +41.6% |
| 2013 | CN¥733.22 Million | CN¥832.55 Million | CN¥99.33 Million | — |